Oral tofacitinib monotherapy in Korean patients with refractory moderate-to-severe alopecia areata: A case series

To the Editor: Recent reports document successful treatment of alopecia areata (AA) with tofacitinib.1-5 However, long-term data using tofacitinib monotherapy is still sparse, and we are unaware of the quality of treatment in persons of Asian decent. We report the results of extended tofacitinib monotherapy in adult Korean patients with moderate-to-severe AA.